Abstract

Apoptosis, the cell’s natural mechanism for death, is a promising target for anticancer therapy. Both the intrinsic and extrinsic pathways use caspases to carry out apoptosis through the cleavage of hundreds of proteins. In cancer, the apoptotic pathway is typically inhibited through a wide variety of means including overexpression of antiapoptotic proteins and under-expression of proapoptotic proteins. Many of these changes cause intrinsic resistance to the most common anticancer therapy, chemotherapy. Promising new anticancer therapies are plant-derived compounds that exhibit anticancer activity through activating the apoptotic pathway.

Keywords

ApoptosisCaspaseIntrinsic apoptosisProgrammed cell deathCancer researchCancer therapyBiologyMechanism (biology)Cell biologyCancerChemistryBioinformaticsBiochemistryGenetics

MeSH Terms

AnimalsAntineoplastic AgentsPhytogenicApoptosisCarcinogenesisCaspasesCell LineTumorCurcuminFas Ligand ProteinGene Expression RegulationNeoplasticHumansMiceMolecular Targeted TherapyNeoplasmsProto-Oncogene Proteins c-bcl-2Signal Transductionbcl-2-Associated X Proteinfas Receptor

Affiliated Institutions

Related Publications

Publication Info

Year
2018
Type
review
Volume
19
Issue
2
Pages
448-448
Citations
1480
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1480
OpenAlex
32
Influential
1257
CrossRef

Cite This

Claire M. Pfeffer, Amareshwar T.K. Singh (2018). Apoptosis: A Target for Anticancer Therapy. International Journal of Molecular Sciences , 19 (2) , 448-448. https://doi.org/10.3390/ijms19020448

Identifiers

DOI
10.3390/ijms19020448
PMID
29393886
PMCID
PMC5855670

Data Quality

Data completeness: 90%